Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of SOTAC PHARMACEUTICALS LTD.. For more details, see the SOTAC PHARMACEUTICALS LTD. quarterly results and SOTAC PHARMACEUTICALS LTD. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.0 |
No. of shares | m | 11.05 |
1 Week | % | 0.0 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 155.0/97.0 |
No. of Mths Year Ending |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SOTAC PHARMACEUTICALS LTD. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | NA | ||
Low | Rs | NA | NA | NA | NA | ||
Sales per share (Unadj.) | Rs | 124.4 | 212.4 | 318.1 | 96.3 | ||
Earnings per share (Unadj.) | Rs | 0.4 | -10.3 | 12.5 | 2.8 | ||
Diluted earnings per share | Rs | 0.1 | -2.1 | 2.6 | 2.1 | ||
Cash flow per share (Unadj.) | Rs | 6.5 | 1.0 | 17.4 | 5.7 | ||
Dividends per share (Unadj.) | Rs | 0 | 0 | 2.00 | 0 | ||
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.42 | 0.00 | ||
Avg Dividend yield | % | 0 | 0 | 0 | 0 | ||
Book value per share (Unadj.) | Rs | 13.3 | 10.8 | 28.8 | 12.4 | ||
Adj. book value per share | Rs | 2.8 | 2.3 | 6.0 | 9.0 | ||
Shares outstanding (eoy) | m | 2.30 | 2.30 | 2.30 | 8.05 | ||
Price / Sales ratio | x | 0 | 0 | 0 | 0 | ||
Avg P/E ratio | x | 0 | 0 | 0 | 0 | ||
P/CF ratio (eoy) | x | 0 | 0 | 0 | 0 | ||
Price / Book Value ratio | x | 0 | 0 | 0 | 0 | ||
Dividend payout | % | 0 | 0 | 16.0 | 0 | ||
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 0 | ||
Total wages/salary | Rs m | 14 | 25 | 22 | 26 |
SOTAC PHARMACEUTICALS LTD. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 286 | 488 | 732 | 775 | ||
Other income | Rs m | 2 | 1 | 2 | 4 | ||
Total revenues | Rs m | 288 | 490 | 734 | 778 | ||
Gross profit | Rs m | 19 | 15 | 62 | 79 | ||
Depreciation | Rs m | 14 | 26 | 11 | 23 | ||
Interest | Rs m | 3 | 10 | 6 | 20 | ||
Profit before tax | Rs m | 4 | -21 | 47 | 39 | ||
Minority Interest | Rs m | 0 | 0 | 0 | 0 | ||
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | ||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | ||
Tax | Rs m | 3 | 3 | 18 | 16 | ||
Profit after tax | Rs m | 1 | -24 | 29 | 23 | ||
Gross profit margin | % | 6.5 | 3.0 | 8.4 | 10.2 | ||
Effective tax rate | % | 75.5 | -15.0 | 38.7 | 41.8 | ||
Net profit margin | % | 0.3 | -4.8 | 3.9 | 3.0 |
SOTAC PHARMACEUTICALS LTD. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 137 | 173 | 259 | 471 | ||
Current liabilities | Rs m | 193 | 228 | 276 | 458 | ||
Net working cap to sales | % | -19.6 | -11.1 | -2.4 | 1.7 | ||
Current ratio | x | 0.7 | 0.8 | 0.9 | 1.0 | ||
Inventory Days | Days | 10 | 7 | 3 | 3 | ||
Debtors Days | Days | 888 | 440 | 611 | 704 | ||
Net fixed assets | Rs m | 166 | 173 | 94 | 265 | ||
Share capital | Rs m | 23 | 23 | 23 | 81 | ||
"Free" reserves | Rs m | 8 | 2 | 43 | 19 | ||
Net worth | Rs m | 31 | 25 | 66 | 100 | ||
Long term debt | Rs m | 61 | 93 | 10 | 78 | ||
Total assets | Rs m | 304 | 347 | 352 | 736 | ||
Interest coverage | x | 2.1 | -1.0 | 9.2 | 2.9 | ||
Debt to equity ratio | x | 2.0 | 3.7 | 0.1 | 0.8 | ||
Sales to assets ratio | x | 0.9 | 1.4 | 2.1 | 1.1 | ||
Return on assets | % | 1.4 | -3.9 | 9.8 | 5.9 | ||
Return on equity | % | 2.9 | -94.8 | 43.5 | 22.9 | ||
Return on capital | % | 7.5 | -8.8 | 69.3 | 33.6 | ||
Exports to sales | % | 0 | 0 | 0 | 0 | ||
Imports to sales | % | 0 | 0 | 0 | 0 | ||
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | ||
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | ||
Fx inflow | Rs m | 0 | 0 | 1 | 0 | ||
Fx outflow | Rs m | 0 | 0 | 0 | 0 | ||
Net fx | Rs m | 0 | 0 | 1 | 0 |
SOTAC PHARMACEUTICALS LTD. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1 | -3 | 64 | 81 | ||
From Investments | Rs m | -117 | -32 | -35 | -117 | ||
From Financial Activity | Rs m | 114 | 34 | -28 | 131 | ||
Net Cashflow | Rs m | -3 | -2 | 0 | 96 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Sharadkumar Dashrathbhai Patel | COMP SEC: Niyati Parikh | YEAR OF INC: 2015 | NSE CODE: 99316 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare SOTAC PHARMACEUTICALS LTD. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day weak, Indian share markets pared losses as the session progressed and ended the day higher.